BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy In Breaking, Federal, Pharma Industry, RegulatoryAugust 17, 2020 Tom Mirga SPONSORED BY … Read More »
Health Centers Seek Meeting With Merck About its 340B Contract Pharmacy Data Request In Federal, Pharma Industry, Regulatory, Trade AssociationAugust 11, 2020 Tom Mirga SPONSORED BY A … Read More »
Sanofi Joins Growing List of Drug Companies Challenging 340B Contract Pharmacy In Federal, Pharma Industry, RegulatoryJuly 28, 2020 Tom Mirga SPONSORED BY Note … Read More »
BREAKING: Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions In Breaking, Federal, Pharma Industry, Regulatory, Trade AssociationJuly 17, 2020 Tom Mirga SPONSORED BY … Read More »
340B ESP Wants to Be Pharma’s Go-to on 340B Duplicate Discounts. Kalderos Says Not So Fast. In Federal, Other Industry, Pharma IndustryJuly 16, 2020 Tom Mirga SPONSORED BY A … Read More »
Eli Lilly Says It Doesn’t Have to Provide 340B-Priced Drugs to Contract Pharmacies In Federal, Pharma Industry, RegulatoryJuly 7, 2020 Tom Mirga SPONSORED BY A … Read More »
340B Drug Manufacturer Audits: A Q&A with HRSA In Federal, Pharma Industry, RegulatoryJune 18, 2020 Tom Mirga SPONSORED BY A … Read More »
HRSA Takes Step to Improve 340B Pricing Consistency In Federal, Pharma Industry, RegulatoryJune 16, 2020 Tom Mirga SPONSORED BY A … Read More »
DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges In Federal, Judicial, Pharma Industry, RegulatoryMarch 5, 2020 Tom Mirga If Mallinckrodt settles charges it evaded … Read More »
340B Providers Could Face Drug Access Challenges Due to Coronavirus In Federal, Pharma Industry, RegulatoryMarch 3, 2020 Tom Mirga An electron microscope image of SARS-CoV2 … Read More »
